Literature DB >> 20206223

Impairment of in vitro generation of monocyte-derived human dendritic cells by inactivated human immunodeficiency virus-1: Involvement of type I interferon produced from plasmacytoid dendritc cells.

Akira Kodama1, Reiko Tanaka, Li Feng Zhang, Tetsuya Adachi, Mineki Saito, Aftab A Ansari, Yuetsu Tanaka.   

Abstract

In an attempt to simplify the protocol of DC generation in vitro, studies conducted herein show that functional DCs could be generated from bulk peripheral blood mononuclear cells (PBMCs) in media containing GM-CSF and IL-4. Interestingly, when PBMCs, but not purified monocytes, were exposed to either CCR5- or CXCR4-tropic inactivated HIV-1 isolates (iHIV-1) at the initiation of the culture, DC yields were significantly reduced in a dose-dependent manner because of monocyte apoptosis. Similar impairment of DC generation was noted using type I IFNs and poly IC not only in cultures of PBMCs but also using highly enriched monocytes. This effect was reversed by antihuman type I IFN receptor, but not by anti-FasL, anti-TRAIL, anti-TNF, or a mixture of these antibodies. iHIV-1-exposed PBMCs, but not monocytes, produced high levels of IFN-alpha but not IFN-beta. PBMCs depleted of CD123(+) plasmacytoid DCs produced low levels of IFN-alpha and were resistant to iHIV-1-mediated DC impairment. Interestingly, exogenously added TNF reversed the impairment by iHIV-1 in the PBMC cultures. In conclusion, the present results indicate that iHIV-1 impairs the in vitro generation of functional DCs from PBMCs through the induction of IFN-alpha from plasmacytoid DCs in a CD4-dependent fashion in the absence of TNF. Copyright 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206223     DOI: 10.1016/j.humimm.2010.02.020

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

Review 1.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 2.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 3.  Human Immunodeficiency Virus Infection and Host Defense in the Lungs.

Authors:  Tysheena P Charles; Judd E Shellito
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

Review 4.  Dendritic cells in progression and pathology of HIV infection.

Authors:  Olivier Manches; Davor Frleta; Nina Bhardwaj
Journal:  Trends Immunol       Date:  2013-11-15       Impact factor: 16.687

Review 5.  Dendritic Cells, the Double Agent in the War Against HIV-1.

Authors:  Alba Martín-Moreno; Mª Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

6.  Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.

Authors:  Yongxiong Chen; Shiuh-Lin Hwang; Vera S F Chan; Nancy P Y Chung; Shu-Rong Wang; Zhongye Li; Jing Ma; Chia-Wei Lin; Ya-Ju Hsieh; Kao-Ping Chang; Sui-Sum Kung; Yi-Chia Wu; Cheng-Wei Chu; Hsiao-Ting Tai; George F Gao; Bojian Zheng; Kazunari K Yokoyama; Jonathan M Austyn; Chen-Lung S Lin
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

7.  A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice.

Authors:  Akira Kodama; Reiko Tanaka; Mineki Saito; Aftab A Ansari; Yuetsu Tanaka
Journal:  Front Microbiol       Date:  2013-09-27       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.